B-amyloid as a Marker for GBM Bioimaging
Latest Information Update: 26 Dec 2023
At a glance
- Drugs Florbetapir F 18 (Primary)
- Indications Glioblastoma
- Focus Diagnostic use
Most Recent Events
- 20 Dec 2023 Planned End Date changed from 1 Jul 2024 to 1 Jul 2026.
- 20 Dec 2023 Planned primary completion date changed from 1 Jul 2024 to 1 Jul 2026.
- 20 Dec 2023 Planned initiation date changed from 1 Jul 2023 to 1 Jul 2024.